117 related articles for article (PubMed ID: 20568898)
1. Neutrophilic differentiation modulates the apoptotic response of HL-60 cells to sodium butyrate and sodium valproate.
Vrba J; Dolezel P; Ulrichova J
Neoplasma; 2010; 57(5):438-48. PubMed ID: 20568898
[TBL] [Abstract][Full Text] [Related]
2. HDAC inhibitors sodium butyrate and sodium valproate do not affect human ncor1 and ncor2 gene expression in HL-60 cells.
Vrba J; Trtkova K; Ulrichova J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):259-62. PubMed ID: 22286811
[TBL] [Abstract][Full Text] [Related]
3. Modulation of ionizing radiation-induced apoptosis and cell cycle arrest by all-trans retinoic acid in promyelocytic leukemia cells (HL-60).
Mareková M; Vávrová J; Vokurková D; Psutka J
Physiol Res; 2003; 52(5):599-606. PubMed ID: 14535836
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid and butyrate induce apoptosis in human cancer cells through inhibition of gene expression of Akt/protein kinase B.
Chen J; Ghazawi FM; Bakkar W; Li Q
Mol Cancer; 2006 Dec; 5():71. PubMed ID: 17156483
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 inhibits all-trans retinoic acid-induced apoptosis.
Soucek K; Pacherník J; Kubala L; Vondrácek J; Hofmanová J; Kozubík A
Leuk Res; 2006 May; 30(5):607-23. PubMed ID: 16242776
[TBL] [Abstract][Full Text] [Related]
6. Thrombomodulin induction by all-trans retinoic acid is independent of HL-60 cells differentiation to neutrophilic cells.
Kizaki K; Ishii H; Horie S; Kazama M
Thromb Haemost; 1994 Oct; 72(4):573-7. PubMed ID: 7878635
[TBL] [Abstract][Full Text] [Related]
7. The role and possible molecular mechanism of valproic acid in the growth of MCF-7 breast cancer cells.
Ma XJ; Wang YS; Gu WP; Zhao X
Croat Med J; 2017 Oct; 58(5):349-357. PubMed ID: 29094813
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of poly(ADP-ribose) polymerase promotes cell cycle arrest and inhibits neutrophilic differentiation of NB4 acute promyelocytic leukemia cells.
Bhatia M; Kirkland JB; Meckling-Gill KA
Cell Growth Differ; 1996 Jan; 7(1):91-100. PubMed ID: 8788037
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts.
Bernhard D; Ausserlechner MJ; Tonko M; Löffler M; Hartmann BL; Csordas A; Kofler R
FASEB J; 1999 Nov; 13(14):1991-2001. PubMed ID: 10544182
[TBL] [Abstract][Full Text] [Related]
10. Differential cell fates induced by all-trans retinoic acid-treated HL-60 human leukemia cells.
Ozeki M; Shively JE
J Leukoc Biol; 2008 Sep; 84(3):769-79. PubMed ID: 18552205
[TBL] [Abstract][Full Text] [Related]
11. Thwarting PTEN Expression by siRNA Augments HL-60 Cell Differentiation to Neutrophil-Like Cells by DMSO and ATRA.
Teimourian S; Moghanloo E
DNA Cell Biol; 2016 Oct; 35(10):591-598. PubMed ID: 27617494
[TBL] [Abstract][Full Text] [Related]
12. Sodium butyrate induced keratinocyte apoptosis.
Daehn IS; Varelias A; Rayner TE
Apoptosis; 2006 Aug; 11(8):1379-90. PubMed ID: 16761108
[TBL] [Abstract][Full Text] [Related]
13. The effect of sodium butyrate in combination with ATRA on the proliferation/differentiation of SKM-1.
Huang M; Liu W; Li C; Deng J; Zhou J; Zhang D; Sun H
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(4):334-7. PubMed ID: 15587392
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by combined treatment with differentiation-inducing agents and interferon-alpha in human lung cancer cells.
Yamamoto-Yamaguchi Y; Okabe-Kado J; Kasukabe T; Honma Y
Anticancer Res; 2003; 23(3B):2537-47. PubMed ID: 12894538
[TBL] [Abstract][Full Text] [Related]
15. RB phosphorylation in sodium butyrate-resistant HL-60 cells: cross-resistance to retinoic acid but not vitamin D3.
Yen A; Varvayanis S
J Cell Physiol; 1995 Jun; 163(3):502-9. PubMed ID: 7775593
[TBL] [Abstract][Full Text] [Related]
16. [Inhibition of proliferation and induction of apoptosis and differentiation of leukemic cell line HL-60 by sodium valproate].
Han DM; Chen XQ; Liang R; Dong BX; Yin W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):21-4. PubMed ID: 16584584
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors induce cell death and enhance the apoptosis-inducing activity of TRAIL in Ewing's sarcoma cells.
Sonnemann J; Dreyer L; Hartwig M; Palani CD; Hong le TT; Klier U; Bröker B; Völker U; Beck JF
J Cancer Res Clin Oncol; 2007 Nov; 133(11):847-58. PubMed ID: 17486365
[TBL] [Abstract][Full Text] [Related]
18. Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast cancer and leukemia cell lines.
Foglietta F; Serpe L; Canaparo R; Vivenza N; Riccio G; Imbalzano E; Gasco P; Zara GP
J Pharm Pharm Sci; 2014; 17(2):231-47. PubMed ID: 24934552
[TBL] [Abstract][Full Text] [Related]
19. The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells.
Giuliano M; Lauricella M; Calvaruso G; Carabillò M; Emanuele S; Vento R; Tesoriere G
Cancer Res; 1999 Nov; 59(21):5586-95. PubMed ID: 10554039
[TBL] [Abstract][Full Text] [Related]
20. Effect of histone deacetylase inhibitors trichostatin A and valproic acid on etoposide-induced apoptosis in leukemia cells.
Jasek E; Lis GJ; Jasinska M; Jurkowska H; Litwin JA
Anticancer Res; 2012 Jul; 32(7):2791-9. PubMed ID: 22753739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
